CeNeRx BioPharma, Inc.: Series D $4.6M

Posted in I - Series C, Q - 4Q11, R - SOUTH EAST, X - Anxiety, X - CNS, X - Depression, XX - NC

CeNeRx (Cary, NC) a clinical-stage biopharmaceutical company focused on diseases of the central nervous system, depression and anxiety, closed a $4.6M Series D financing. Participants include Aisling Capital, L Capital Partners, Perseus Soros Biopharmaceutical Fund, Omega Funds and Pappas Ventures.

Breathe America, Inc.: Series B $22M

Posted in I - Series B, Q - 3Q11, R - SOUTH EAST, X - Allergy, X - Asthma, X - Sinus, XX - TN

Breathe America (Nashville, TN) a commercial-stage clinical company focused on the treatment of chronic airway diseases, allergy, sinus and asthma, closed a $22M Series B financing. Participants include Essex Woodlands.
Thanx for your patience as we catch-up.

Embera NeuroTherapeutics, Inc.: Series A $4.5M

Posted in I - Series A, Q - 3Q11, R - SOUTH EAST, X - Addiction, XX - LA

Embera NeuroTherapeutics (Shreveport, LA) a development stage pharmaceutical company focused on treatments for smoking cessation and other addictions, closed a $4.5M Series A financing. Participants include Louisiana Ventures, Louisiana Fund and Themelios Ventures.
Thanx for your patience as we catch-up.

Metabolon, Inc.: Series D $13.1M

Posted in I - Series D, Q - 3Q11, R - SOUTH EAST, X - Device (Diagnostic), XX - NC

Metabolon (Durham, NC) a commercial-stage provider of biomarker discovery and analysis, closed a $13.1M Series D financing. Participants include Keating Capital, Sevin Rosen Funds, Aurora Funds, Harris & Harris Group, Syngenta Ventures and Fletcher Spaght.

Clinipace Worldwide, Inc.: Series C $15M

Posted in I - Series C, Q - 3Q11, R - SOUTH EAST, X - CRO, XX - NC

Clinipace Worldwide (Durham, NC) a commercial-stage global digital clinical research organization specializing in strategic product and clinical development, closed a $15M Series C financing. Participants include Morgan Stanley, Hatteras Venture Partners and Brook Private Equity Advisors.
The 3Q11 OnBioVC Trend Analysis Will Be Available Next Monday 31 October

CareCloud, Inc.: Series A $20.1M

Posted in I - Series A, Q - 3Q11, R - SOUTH EAST, X - TeleMedicine, XX - FL

CareCloud (Miami, FL) a commercial-stage developer provider of cloud-based healthcare management software, closed a $20.1M Series A financing. Participants include Intel Capital and Norwest Venture Partners.

Esperance Pharmaceuticals, Inc.: Series B $7.5M

Posted in I - Series B, Q - 2Q11, R - SOUTH EAST, X - Oncology, X - Therapeutic Platform, XX - LA

Esperance Pharmaceuticals (Baton Rouge, LA) a clinical-stage oncology and companion diagnostic company, closed a $7.5M Series B financing. Participants include Sanofi, Louisiana Fund, Themelios Ventures, Research Corporation Technologies and Advantage Capital Partners.

OrthoSensor, Inc.: Series B $21M

Posted in I - Series B, Q - 1Q11, R - SOUTH EAST, X - Device (Monitoring), X - Device (Orthopedic), XX - FL

OrthoSensor (Sunrise, FL) a development-stage medical device company focused on remote monitoring of orthopedic implants, closed a $21M Series B financing. Participants include Ziegler Meditech Equity Partners.

Advanced Animal Diagnostics, Inc.: Series B $11M

Posted in I - Series B, Q - 1Q11, R - SOUTH EAST, X - Device (Diagnostic), XX - NC

Advanced Animal Diagnostics (Durham, NC) a commercial-stage developer of farm animal diagnostics focused on the detection of mastitis in dairy cows, closed a $11M Series B financing. Participants include Intersouth Partners and Novartis Venture Funds.

Chimerix, Inc.: Series F $45M

Posted in I - Series F, Q - 1Q11, R - SOUTH EAST, X - Antiviral, X - CMV, XX - NC

Chimerix (Durham, NC) a clinical-stage pharma company developing broad spectrum antiviral agents focusing on CMV and BK viruria, closed a $45M Series F financing. Participants include Pappas Ventures, Morningside Group, Sanderling Ventures, Canaan Partners, Alta Partners, Asset Management Co., Frazier Healthcare Ventures and New Leaf Venture Partners.

Arbor Pharmaceuticals, Inc.: Series B $17.5M

Posted in I - Series B, Q - 4Q10, R - SOUTH EAST, X - Dermatology, X - Hearing Loss, X - Otic, XX - GA

Arbor Pharmaceuticals (Atlanta, GA) a commercial-stage specialty pharmaceutical company atopic dermatitis and otic conditions, closed a $17.5M Series B financing. Participants include Signet Healthcare Partners.

nContact Surgical, Inc.: Series D $16M

Posted in I - Series D, Q - 4Q10, R - SOUTH EAST, X - Device (Cardiology), XX - NC

nContact Surgical (Morisville, NC) a clinical-stage medical device company focused on minimally invasive hearth arrhythmias, closed a $16M Series D financing. Participants include Harbert Venture Partners, Intersouth Partners, Massey Burch, Tall Oaks Capital, Village Ventures, Finistere Ventures, Hippo Ventures and ZMV Associates.

Watermark Medical, Inc.: Series B $6M

Posted in I - Series B, Q - 3Q10, R - SOUTH EAST, X - Device (Sleep Apnea), XX - FL

Watermark Medical (Boca Raton, FL) a commercial-stage medical device company focused on sleep apnea, closed a $6M Series B financing. Participants include Ballast Point Ventures.

« Previous Entries

to top of page...